A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin/Cisplatin and Paclitaxel) in Patients With Advanced Cervical Cancer